Abstract
Induced pluripotent stem cells offer the possibility to generate patient-specific stem cell lines from individuals affected by inherited disorders. Cardiomyocytes differentiated from such patient-specific induced pluripotent stem cells lines have been used to study the pathophysiology of arrhythmogenic heart diseases, such as the long-QT syndrome or catecholaminergic polymorphic ventricular tachycardia. Testing for unwanted drug side effects or tailoring medical treatment to the specific needs of individual patients with arrhythmogenic disorders may become future applications of this emerging technology.
| Original language | English |
|---|---|
| Pages (from-to) | 961-968 |
| Number of pages | 8 |
| Journal | Circulation Research |
| Volume | 112 |
| Issue number | 6 |
| DOIs | |
| State | Published - 15 Mar 2013 |
Keywords
- catecholaminergic polymorphic ventricular tachycardia
- disease modeling
- long-QT syndrome
- reprogramming